Medtronic, Inc.'s $1 Billion Fumble Could Chill Risk-Taking

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The recent collapse of Medtronic’s clinical trial for a blood pressure treatment device marks another watershed as the era of dynamic growth through invention comes to a close in the medical device industry. Yes, it’s just one patient trial for one product. But it’s not every day that doubts about whether a medical device actually works take a billion-dollar acquisition down more or less to zero.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC